PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Active compounds
Mechanism of action
Clinical evidence
Crude bark extract showed antileishmanial activity (IC50 < 12.5 μg/mL) against L. amazonensis; specifically, sesamin exhibited an IC50 of 15.8 μg/mL without cytotoxicity to mouse macrophage cells [PMID: 26411017]
Evidence summary
PubMed sources
- 1.PMID: 21708553 (1997) — The mode of origin of root buds and root sprouts in the clonal tree Sassafras albidum (Lauraceae). · American journal of botany
- 2.PMID: 36987107 (2023) — Phylogeny and Systematics of Sassafras (Lauraceae), an Interesting Genus with Disjunct Distributions in Eastern North America and East Asia. · Plants (Basel, Switzerland)
- 3.PMID: 10030529 (1999) — Unsafe and potentially safe herbal therapies. · American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
- 4.PMID: 33155339 (2021) — Identification of Sassafras albidum alkaloids by high-performance thin-layer chromatography tandem mass spectrometry and mapping by desorption electrospray ionization mass spectrometry imaging. · Journal of mass spectrometry : JMS
- 5.PMID: 8824955